VBIV Annual EBIT
-$84.77 M
+$23.31 M+21.57%
31 December 2023
Summary:
As of January 27, 2025, VBIV annual earnings before interest & taxes is -$84.77 million, with the most recent change of +$23.31 million (+21.57%) on December 31, 2023. During the last 3 years, it has fallen by -$41.86 million (-97.56%).VBIV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly EBIT
-$15.89 M
-$17.94 M-873.42%
31 March 2024
Summary:
As of January 27, 2025, VBIV quarterly earnings before interest & taxes is -$15.89 million, with the most recent change of -$17.94 million (-873.42%) on March 31, 2024. Over the past year, it has increased by +$26.73 million (+62.73%).VBIV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM EBIT
-$74.84 M
+$9.93 M+11.72%
31 March 2024
Summary:
As of January 27, 2025, VBIV TTM earnings before interest & taxes is -$74.84 million, with the most recent change of +$9.93 million (+11.72%) on March 31, 2024. Over the past year, it has increased by +$36.83 million (+32.98%).VBIV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +21.6% | +62.7% | +33.0% |
3 y3 years | -97.6% | +17.6% | +30.8% |
5 y5 years | -40.5% | +17.6% | +30.8% |
VBIV EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | <-9999.0% | -873.4% | <-9999.0% |
VBI Vaccines EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | - | -$15.89 M(-873.4%) | -$74.84 M(-11.7%) |
Dec 2023 | -$84.77 M(-21.6%) | $2.05 M(-111.2%) | -$84.77 M(-20.1%) |
Sept 2023 | - | -$18.39 M(-56.9%) | -$106.11 M(-5.0%) |
June 2023 | - | -$42.62 M(+65.1%) | -$111.67 M(-1.8%) |
Mar 2023 | - | -$25.82 M(+33.9%) | -$113.66 M(+5.2%) |
Dec 2022 | -$108.08 M(+67.2%) | -$19.29 M(-19.4%) | -$108.08 M(+1.5%) |
Sept 2022 | - | -$23.94 M(-46.4%) | -$106.46 M(+9.5%) |
June 2022 | - | -$44.62 M(+120.5%) | -$97.26 M(+40.5%) |
Mar 2022 | - | -$20.24 M(+14.6%) | -$69.24 M(+7.1%) |
Dec 2021 | -$64.65 M(+50.7%) | -$17.67 M(+19.8%) | -$64.65 M(+5.2%) |
Sept 2021 | - | -$14.74 M(-11.2%) | -$61.46 M(+4.5%) |
June 2021 | - | -$16.59 M(+6.1%) | -$58.82 M(+15.5%) |
Mar 2021 | - | -$15.65 M(+8.1%) | -$50.91 M(+18.7%) |
Dec 2020 | -$42.91 M(-17.1%) | -$14.47 M(+19.5%) | -$42.91 M(+11.2%) |
Sept 2020 | - | -$12.11 M(+39.4%) | -$38.57 M(-7.9%) |
June 2020 | - | -$8.69 M(+13.6%) | -$41.87 M(-8.2%) |
Mar 2020 | - | -$7.64 M(-24.6%) | -$45.59 M(-12.0%) |
Dec 2019 | -$51.78 M(-14.2%) | -$10.14 M(-34.2%) | -$51.78 M(-13.8%) |
Sept 2019 | - | -$15.41 M(+24.2%) | -$60.04 M(+1.5%) |
June 2019 | - | -$12.40 M(-10.3%) | -$59.16 M(-5.7%) |
Mar 2019 | - | -$13.83 M(-24.8%) | -$62.70 M(+3.9%) |
Dec 2018 | -$60.35 M(+65.8%) | -$18.40 M(+26.7%) | -$60.35 M(+14.5%) |
Sept 2018 | - | -$14.53 M(-8.9%) | -$52.72 M(+11.6%) |
June 2018 | - | -$15.95 M(+39.0%) | -$47.23 M(+19.5%) |
Mar 2018 | - | -$11.48 M(+6.6%) | -$39.54 M(+8.5%) |
Dec 2017 | -$36.40 M(+47.6%) | -$10.77 M(+19.2%) | -$36.43 M(+2.3%) |
Sept 2017 | - | -$9.03 M(+9.4%) | -$35.62 M(+5.3%) |
June 2017 | - | -$8.26 M(-1.3%) | -$33.82 M(+5.8%) |
Mar 2017 | - | -$8.37 M(-16.0%) | -$31.97 M(+29.6%) |
Dec 2016 | -$24.66 M(-2.2%) | -$9.96 M(+37.6%) | -$24.66 M(-23.2%) |
Sept 2016 | - | -$7.24 M(+12.8%) | -$32.11 M(+8.0%) |
June 2016 | - | -$6.41 M(+508.4%) | -$29.74 M(+22.5%) |
Mar 2016 | - | -$1.05 M(-93.9%) | -$24.28 M(+1.7%) |
Dec 2015 | -$25.22 M(+509.5%) | -$17.41 M(+257.6%) | -$23.86 M(+203.8%) |
Sept 2015 | - | -$4.87 M(+413.5%) | -$7.85 M(+86.2%) |
June 2015 | - | -$948.00 K(+48.1%) | -$4.22 M(-1.1%) |
Mar 2015 | - | -$640.00 K(-54.2%) | -$4.27 M(-17.8%) |
Mar 2015 | -$4.14 M(-21.8%) | - | - |
Dec 2014 | - | -$1.40 M(+13.5%) | -$5.19 M(-10.6%) |
Sept 2014 | - | -$1.23 M(+24.0%) | -$5.80 M(+4.0%) |
June 2014 | - | -$994.00 K(-36.3%) | -$5.58 M(+4.7%) |
Mar 2014 | -$5.29 M(-28.3%) | -$1.56 M(-22.5%) | -$5.33 M(+19.3%) |
Dec 2013 | - | -$2.01 M(+99.1%) | -$4.47 M(+16.7%) |
Sept 2013 | - | -$1.01 M(+36.3%) | -$3.83 M(-34.3%) |
June 2013 | - | -$742.30 K(+6.4%) | -$5.82 M(-20.9%) |
Mar 2013 | -$7.38 M(-45.8%) | -$697.80 K(-49.3%) | -$7.36 M(-27.5%) |
Dec 2012 | - | -$1.38 M(-54.2%) | -$10.16 M(-12.6%) |
Sept 2012 | - | -$3.01 M(+32.0%) | -$11.62 M(-3.2%) |
June 2012 | - | -$2.28 M(-34.8%) | -$12.01 M(-12.8%) |
Mar 2012 | -$13.61 M(-46.3%) | -$3.49 M(+22.9%) | -$13.76 M(-52.0%) |
Dec 2011 | - | -$2.84 M(-16.1%) | -$28.65 M(+3.4%) |
Sept 2011 | - | -$3.39 M(-16.0%) | -$27.70 M(-0.6%) |
June 2011 | - | -$4.04 M(-78.0%) | -$27.87 M(+10.8%) |
Mar 2011 | -$25.33 M | -$18.38 M(+869.4%) | -$25.15 M(+250.8%) |
Dec 2010 | - | -$1.90 M(-46.7%) | -$7.17 M(+32.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2010 | - | -$3.55 M(+168.7%) | -$5.43 M(+177.2%) |
June 2010 | - | -$1.32 M(+232.9%) | -$1.96 M(+171.9%) |
Mar 2010 | -$731.60 K(+183.3%) | -$397.30 K(+150.7%) | -$720.80 K(+85.1%) |
Dec 2009 | - | -$158.50 K(+94.0%) | -$389.40 K(+31.9%) |
Sept 2009 | - | -$81.70 K(-1.9%) | -$295.20 K(-2.4%) |
June 2009 | - | -$83.30 K(+26.4%) | -$302.50 K(+8.2%) |
Mar 2009 | -$258.20 K(-55.2%) | -$65.90 K(+2.5%) | -$279.70 K(-17.8%) |
Dec 2008 | - | -$64.30 K(-27.8%) | -$340.20 K(-22.7%) |
Sept 2008 | - | -$89.00 K(+47.1%) | -$440.30 K(-20.2%) |
June 2008 | - | -$60.50 K(-52.1%) | -$551.60 K(-3.2%) |
Mar 2008 | -$576.00 K(+55.0%) | -$126.40 K(-23.1%) | -$569.70 K(-4.4%) |
Dec 2007 | - | -$164.40 K(-17.9%) | -$596.00 K(+20.6%) |
Sept 2007 | - | -$200.30 K(+154.8%) | -$494.00 K(+27.7%) |
June 2007 | - | -$78.60 K(-48.5%) | -$386.70 K(+2.2%) |
Mar 2007 | -$371.50 K(-10.4%) | -$152.70 K(+144.7%) | -$378.30 K(-26.5%) |
Dec 2006 | - | -$62.40 K(-32.9%) | -$514.70 K(+5.5%) |
Sept 2006 | - | -$93.00 K(+32.5%) | -$488.00 K(+10.3%) |
June 2006 | - | -$70.20 K(-75.7%) | -$442.40 K(+6.9%) |
Mar 2006 | -$414.70 K(+206.3%) | -$289.10 K(+709.8%) | -$414.00 K(+118.6%) |
Dec 2005 | - | -$35.70 K(-24.7%) | -$189.40 K(+11.0%) |
Sept 2005 | - | -$47.40 K(+13.4%) | -$170.70 K(+18.0%) |
June 2005 | - | -$41.80 K(-35.2%) | -$144.70 K(+16.5%) |
Mar 2005 | -$135.40 K(+2.5%) | -$64.50 K(+279.4%) | -$124.20 K(+48.9%) |
Dec 2004 | - | -$17.00 K(-20.6%) | -$83.40 K(-25.9%) |
Sept 2004 | - | -$21.40 K(+0.5%) | -$112.50 K(-7.2%) |
June 2004 | - | -$21.30 K(-10.1%) | -$121.20 K(-6.4%) |
Mar 2004 | -$132.10 K(+62.1%) | -$23.70 K(-48.6%) | -$129.50 K(-10.4%) |
Dec 2003 | - | -$46.10 K(+53.2%) | -$144.50 K(+34.3%) |
Sept 2003 | - | -$30.10 K(+1.7%) | -$107.60 K(+11.4%) |
June 2003 | - | -$29.60 K(-23.5%) | -$96.60 K(+24.3%) |
Mar 2003 | -$81.50 K(+15.8%) | -$38.70 K(+320.7%) | -$77.70 K(+12.6%) |
Dec 2002 | - | -$9200.00(-51.8%) | -$69.00 K(-3.2%) |
Sept 2002 | - | -$19.10 K(+78.5%) | -$71.30 K(+13.5%) |
June 2002 | - | -$10.70 K(-64.3%) | -$62.80 K(-11.9%) |
Mar 2002 | -$70.40 K(<-9900.0%) | -$30.00 K(+160.9%) | -$71.30 K(-363.1%) |
Dec 2001 | - | -$11.50 K(+8.5%) | $27.10 K(+67.3%) |
Sept 2001 | - | -$10.60 K(-44.8%) | $16.20 K(+376.5%) |
June 2001 | - | -$19.20 K(-128.1%) | $3400.00(-96.2%) |
Mar 2001 | $0.00(-100.0%) | $68.40 K(-405.4%) | $90.10 K(+311.4%) |
Dec 2000 | - | -$22.40 K(-4.3%) | $21.90 K(-80.7%) |
Sept 2000 | - | -$23.40 K(-134.7%) | $113.30 K(-17.1%) |
June 2000 | - | $67.50 K(>+9900.0%) | $136.70 K(-0.2%) |
Mar 2000 | -$68.80 K(-48.1%) | $200.00(-99.7%) | $137.00 K(+3086.0%) |
Dec 1999 | - | $69.00 K(>+9900.0%) | $4300.00(+1333.3%) |
Sept 1999 | - | $0.00(-100.0%) | $300.00(0.0%) |
June 1999 | - | $67.80 K(-151.2%) | $300.00(-50.0%) |
Mar 1999 | -$132.50 K(+88.2%) | -$132.50 K(-303.8%) | $600.00(-99.0%) |
Dec 1998 | - | $65.00 K(>+9900.0%) | $62.70 K(-7.2%) |
Sept 1998 | - | $0.00(-100.0%) | $67.60 K(-51.7%) |
June 1998 | - | $68.10 K(-196.7%) | $140.00 K(-3.0%) |
Mar 1998 | -$70.40 K(-2.9%) | -$70.40 K(-200.7%) | $144.30 K(-32.8%) |
Dec 1997 | - | $69.90 K(-3.5%) | $214.70 K(+48.3%) |
Sept 1997 | - | $72.40 K(0.0%) | $144.80 K(+100.0%) |
June 1997 | - | $72.40 K | $72.40 K |
Mar 1997 | -$72.50 K | - | - |
FAQ
- What is VBI Vaccines annual earnings before interest & taxes?
- What is the all time high annual EBIT for VBI Vaccines?
- What is VBI Vaccines annual EBIT year-on-year change?
- What is VBI Vaccines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for VBI Vaccines?
- What is VBI Vaccines quarterly EBIT year-on-year change?
- What is VBI Vaccines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for VBI Vaccines?
- What is VBI Vaccines TTM EBIT year-on-year change?
What is VBI Vaccines annual earnings before interest & taxes?
The current annual EBIT of VBIV is -$84.77 M
What is the all time high annual EBIT for VBI Vaccines?
VBI Vaccines all-time high annual earnings before interest & taxes is $0.00
What is VBI Vaccines annual EBIT year-on-year change?
Over the past year, VBIV annual earnings before interest & taxes has changed by +$23.31 M (+21.57%)
What is VBI Vaccines quarterly earnings before interest & taxes?
The current quarterly EBIT of VBIV is -$15.89 M
What is the all time high quarterly EBIT for VBI Vaccines?
VBI Vaccines all-time high quarterly earnings before interest & taxes is $2.05 M
What is VBI Vaccines quarterly EBIT year-on-year change?
Over the past year, VBIV quarterly earnings before interest & taxes has changed by +$26.73 M (+62.73%)
What is VBI Vaccines TTM earnings before interest & taxes?
The current TTM EBIT of VBIV is -$74.84 M
What is the all time high TTM EBIT for VBI Vaccines?
VBI Vaccines all-time high TTM earnings before interest & taxes is $214.70 K
What is VBI Vaccines TTM EBIT year-on-year change?
Over the past year, VBIV TTM earnings before interest & taxes has changed by +$36.83 M (+32.98%)